Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Latest Insider Filings for TBP

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Feb 27, 2022 3:43pm

198 Views

Post# 34465978

RE:RE:Latest Insider Filings for TBP

I think he bought at 16c 350k about 57000 c$ during a tax selling he must. He is not living in Quebec that allowed him to buy during the pp other directors not allowed by law. I don't think any of insiders is allowed tobuy now as fda trial coming to an end and they know the results. I loaded below 15c for the past few weeks. I think we all got a decent discount here. Gl to longs

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo